首页> 外文期刊>Advances in Bioscience and Clinical Medicine >Q10 Co-enzyme Effect on Fetus Implantation in ART Cycles
【24h】

Q10 Co-enzyme Effect on Fetus Implantation in ART Cycles

机译:Q10胎儿植入术中的共酶影响

获取原文
       

摘要

Background and Aim: Infertility is a common condition that affects many couples. Although current cutting-edge therapeutic methods have been found promising in this regard, their success still is not sufficiently high. Accordingly, researchers are working to develop new methods to augment the likelihood of successful results of Assisted Reproductive Technology (ART). Recently, coenzyme Q10 has been recognized an important and influential factor in the process of reproduction and some scarce studies have been along favorable results in this regard. This study aims to examine the effect of oral administration of coenzyme Q10 on embryo implantation in ART cycles. Methods and Materials: In this randomized, placebo-controlled clinical trial, a total of 128 infertile females who were candidates for ART were randomized in two groups receiving either a daily capsule of coenzyme Q10 by the commencement of gonadotropin through to pregnancy test result (case group, 64 patients), or placebo (control group, 64 patients). Finally, oocyte count, fertilization rate, embryo count, quality of embryos, transferred embryo count, implantation rate and pregnancy rate were compared between the two groups. Results: The mean age of the patients was 32.77±6.01 years (20-41) in the case group and 32.45±5.93 years (20-42) in the case group, with no significant difference between the two groups (p=0.77). In comparison between the case and control groups, in spite of better results in the case group, no significant difference was found in terms of oocyte count (10.47±7.16 and 9.38±7.52, respectively; p=0.40), fertilization rate (66.88±16.08 % and 66.73±21.50 %, respectively; p=0.96), embryo count (7.03±4.78 and 5.84±4.85, respectively; p=0.17), quality of embryos (71.9% grade I and 28.1% grade II in cases, 68.8% grade I and 31.3% grade II in controls; p=0.70) transferred embryo count (10.9% one, 56.3% two-three and 32.8% more than three in cases, 14% one, 56.3% two-three and 29.7% more than three in controls; p=0.84), implantation rate (8.39±12.73 % and 7.22±12.80 %, respectively; p=0.60), and pregnancy rate (34.4% and 26.6%, respectively; p=0.34). Conclusion: Although using coenzyme Q10, in comparison with placebo, was along with better results in terms of outcome variables of ART, the difference was statistically insignificant possibly because of a small sample size and short duration of the intervention.
机译:背景和目的:不孕症是一种影响许多夫妻的常见条件。虽然目前的尖端治疗方法在这方面已经有望,但它们的成功仍然不够高。因此,研究人员正在努力制定新的方法来增加辅助生殖技术成功结果的可能性(艺术品)。最近,辅酶Q10已经认识到繁殖过程中的一个重要而有影响力的因素,在这方面的一些稀缺研究一直沿着有利的结果。本研究旨在检测口服辅酶Q10对技术循环中胚胎植入的影响。方法和材料:在这种随机,安慰剂对照临床试验中,共有128名不育的女性,艺术候选者在两组中随机化,每次通过促性腺激素的开始通过妊娠试验结果(案例)接受每日辅人Q10的胶囊组,64名患者),或安慰剂(对照组,64名患者)。最后,在两组之间比较了两组之间的卵母细胞计数,施肥率,胚胎计数,胚胎,转移胚胎计数,植入率和妊娠率。结果:患者的平均年龄为32.77±6.01岁(20-41),案例组中32.45±5.93岁(20-42),两组之间无显着差异(P = 0.77) 。在案例和对照组之间进行比较,尽管案例组中的结果更好,但在卵母细胞计数(分别为10.47±7.16和9.38±7.52,P = 0.40),施肥率没有显着差异(66.88±分别为16.08%和66.73±21.50%; p = 0.96),胚胎计数(分别为7.03±4.78和5.84±4.85; p = 0.17),胚胎质量(71.9%等级和28.1%二年级二年级,68.8级II级和31.3%的控制中的II级; P = 0.70)转移胚胎计数(10.9%,56.3%两三和32.8%超过三种,14%,56.3%二三和29.7%超过三种对照; p = 0.84),植入率分别(8.39±12.73%和7.22±12.80%; p = 0.60),妊娠率分别(34.4%和26.6%; P = 0.34)。结论:虽然使用辅酶Q10,与安慰剂相比,随着艺术的结果变量而言,差异是统计上微不足道的,因为介入的小小样和持续时间短。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号